Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Cyclacel Pharmaceuticals Inc. (CYCC)

  • Technical Exchange News
  • June 03, 2025, 19:34 UTC
  • 74
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

bioAffinity Technologies Inc. (BIAFW)

  • Technical Exchange News
  • June 03, 2025, 19:34 UTC
  • 78
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Bluebird bio Inc (BLUE)

  • Technical Exchange News
  • June 03, 2025, 08:15 UTC
  • 68
  • 0 comments

Bluebird bio Inc (BLUE) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

TransCode Therapeutics Inc. (RNAZ)

  • Technical Exchange News
  • June 03, 2025, 01:46 UTC
  • 68
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Moleculin Biotech Inc. (MBRX)

  • Technical Exchange News
  • June 03, 2025, 01:46 UTC
  • 67
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Bluebird bio Inc (BLUE)

  • Technical Exchange News
  • June 03, 2025, 00:57 UTC
  • 61
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: bluebird bio, Inc. - Common Stock.

Comment Full text

Bluebird bio Inc (BLUE)

  • Technical Exchange News
  • June 03, 2025, 00:57 UTC
  • 70
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: bluebird bio, Inc. - Common Stock.

Comment Full text

Bluebird bio Inc (BLUE)

  • Technical Exchange News
  • June 03, 2025, 00:57 UTC
  • 60
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: bluebird bio, Inc. - Common Stock. New value: bluebird bio, Inc. - Common Stock.

Comment Full text

TransCode Therapeutics Inc. (RNAZ)

  • Technical Exchange News
  • June 02, 2025, 19:23 UTC
  • 55
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Moleculin Biotech Inc. (MBRX)

  • Technical Exchange News
  • June 02, 2025, 19:22 UTC
  • 56
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 499
  • 500
  • 501
  • 502
  • 503
  • Next

Search

News categories

  • Technical Exchange News(14281)
  • Event(6229)
  • SEC News(370798)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(227248)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin